STOCK-BASED COMPENSATION PLANS (Details)	1 Months Ended	12 Months Ended
	Dec. 31, 2015 USD ($) Employee $ / shares shares	Sep. 30, 2016 USD ($) Employee Tranche $ / shares shares	Sep. 30, 2015 USD ($) $ / shares shares
Weighted Average Grant-Date Fair Value [Abstract]
Stock based compensation expense | $		$ 754,000	$ 554,000
Unrecognized compensation expense | $		$ 490,830
Weighted average period for unrecognized compensation expense to be recognized		1 year 8 months 12 days
Stock Options [Member]
Outstanding Shares [Abstract]
Outstanding shares, granted (in shares)		95,160
Number of shares of Stock Options [Abstract]
Non-vested balance, beginning of period (in shares)		0
Granted (in shares)		95,160
Cancelled (in shares)		(44,535)
Non-vested balance, end of period (in shares)		50,625	0
Weighted Average Grant-Date Fair Value [Abstract]
Non-vested balance, beginning of period (in dollars per share) | $ / shares		$ 0
Granted (in dollars per share) | $ / shares		4.67
Cancelled (in dollars per share) | $ / shares		0
Non-vested balance, ending of period (in dollars per share) | $ / shares		$ 4.67	$ 0
Number of Tranches | Tranche		2
Estimated fair value of stock at date of grant | $		$ 211,000
Charge to income for restricted stock | $		$ 22,000
Vested options exercisable (in shares)		12,165
Period for vested options exercisable		3 months
Stock Options [Member] | First Tranche [Member]
Number of Shares of Restricted Stock [Roll Forward]
Granted (in shares)		36,496
Weighted Average Grant-Date Fair Value [Abstract]
Exercise price (in dollars per share) | $ / shares		$ 10.93
Stock Options [Member] | Second Tranche [Member]
Number of Shares of Restricted Stock [Roll Forward]
Granted (in shares)		20,204
Weighted Average Grant-Date Fair Value [Abstract]
Exercise price (in dollars per share) | $ / shares		$ 12.35
Stock Options [Member] | Executive and Management [Member]
Fair Value of Stock Options using Black-Scholes-Merton Option-Pricing Model [Abstract]
Expected life		4 years
Risk-free interest rate		1.55%
Volatility		61.43%
Dividend yield		0.00%
Weighted-average fair value per share (in dollars per share) | $ / shares		$ 4.81
Stock Options [Member] | Executive Chairman [Member]
Fair Value of Stock Options using Black-Scholes-Merton Option-Pricing Model [Abstract]
Expected life		4 years
Dividend yield		0.00%
Stock Options [Member] | Executive Chairman [Member] | Minimum [Member]
Fair Value of Stock Options using Black-Scholes-Merton Option-Pricing Model [Abstract]
Risk-free interest rate		0.99%
Volatility		60.45%
Weighted-average fair value per share (in dollars per share) | $ / shares		$ 3.69
Stock Options [Member] | Executive Chairman [Member] | Maximum [Member]
Fair Value of Stock Options using Black-Scholes-Merton Option-Pricing Model [Abstract]
Risk-free interest rate		1.14%
Volatility		64.40%
Weighted-average fair value per share (in dollars per share) | $ / shares		$ 4.03
Restricted Stock [Member]
Number of Shares of Restricted Stock [Roll Forward]
Non-vested balance, beginning of period (in shares)		196,600	168,600
Granted (in shares)		41,240	92,600
Cancelled (in shares)		(3,300)
Vested (in shares)		(95,600)	(64,600)
Non-vested balance, end of period (in shares)		138,940	196,600
Weighted Average Grant-Date Fair Value [Roll Forward]
Non-vested balance, beginning of period (in dollars per share) | $ / shares		$ 5.97	$ 5.27
Granted (in dollars per share) | $ / shares		9.89	7.49
Cancelled (in dollars per share) | $ / shares		9.82
Vested (in dollars per share) | $ / shares		6.77	6.32
Non-vested balance, ending of period (in dollars per share) | $ / shares		$ 6.50	$ 5.97
Restricted Stock [Member] | Nine Non-Employees [Member]
Number of Shares of Restricted Stock [Roll Forward]
Granted (in shares)		29,700
Weighted Average Grant-Date Fair Value [Abstract]
Number of employees directors with restricted stock grant | Employee		9
Estimated fair value of stock at date of grant | $		$ 292,000
Period for recognition of unearned compensation		12 months
Charge to income for restricted stock | $		$ 151,000
Quarterly charge to income for restricted stock | $		$ 65,000
Shares of restricted stock cancelled		(3,300)
Restricted Stock [Member] | Four Employees [Member]
Number of Shares of Restricted Stock [Roll Forward]
Granted (in shares)	11,540
Weighted Average Grant-Date Fair Value [Abstract]
Number of employees directors with restricted stock grant | Employee	4
Estimated fair value of stock at date of grant | $	$ 116,000
Period for recognition of unearned compensation	3 years
Charge to income for restricted stock | $		$ 27,000
Quarterly charge to income for restricted stock | $	$ 9,000
Performance Shares [Member]
Outstanding Shares [Abstract]
Outstanding shares, beginning balance (in shares)		0
Outstanding shares, exercised (in shares)		0
Outstanding shares, forfeited or expired (in shares)		0
Outstanding shares, ending balance (in shares)		38,460	0
Outstanding shares, exercisable (in shares)		0
Outstanding shares, vested and expected to vest (in shares)		35,088
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning balance (in dollars per share) | $ / shares		$ 0
Weighted average exercise price, exercised (in dollars per share) | $ / shares		0
Weighted average exercise price, forfeited or expired (in dollars per share) | $ / shares		0
Weighted average exercise price, ending balance (in dollars per share) | $ / shares		9.94	$ 0
Weighted average exercise price, exercisable (in dollars per share) | $ / shares		0
Weighted average exercise price, vested and expected to vest (in dollars per share) | $ / shares		$ 9.94
Weighted Average Remaining Contractual Term [Abstract]
Weighted average remaining contractual term		4 years 2 months 16 days	0 years
Weighted average remaining contractual term, exercised		0 years
Weighted average remaining contractual term, forfeited or expired		0 years
Weighted average remaining contractual term, exercisable		0 years
Weighted average remaining contractual term, vested and expected to vest		4 years 2 months 16 days
Aggregate Intrinsic Value [Abstract]
Aggregate intrinsic value, beginning balance | $		$ 0
Aggregate intrinsic value, exercised | $		0
Aggregate intrinsic value, forfeited or expired | $		0
Aggregate intrinsic value, ending balance | $		0	$ 0
Aggregate intrinsic value, exercisable | $		0
Aggregate intrinsic value, vested and expected to vest | $		$ 0
Options exercised (in shares)		0
Performance Shares [Member] | Nine Non-Employees [Member]
Weighted Average Grant-Date Fair Value [Abstract]
Number of employees directors with restricted stock grant | Employee	9
Estimated fair value of stock at date of grant | $	$ 185,000
Period for recognition of unearned compensation	3 years
Quarterly charge to income for restricted stock | $	$ 14,000
Exercise price (in dollars per share) | $ / shares	$ 9.94
Performance Shares [Member] | Executive and Management [Member]
Outstanding Shares [Abstract]
Outstanding shares, granted (in shares)		38,460
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, granted (in dollars per share) | $ / shares		$ 9.94
Weighted Average Remaining Contractual Term [Abstract]
Weighted average remaining contractual term, granted		4 years 2 months 16 days
Aggregate Intrinsic Value [Abstract]
Aggregate intrinsic value, granted | $		$ 0
Number of shares of Stock Options [Abstract]
Granted (in shares)		38,460
Time Based Awards [Member]
Outstanding Shares [Abstract]
Outstanding shares, beginning balance (in shares)		0
Outstanding shares, exercised (in shares)		0
Outstanding shares, forfeited or expired (in shares)		(44,535)
Outstanding shares, ending balance (in shares)		12,165	0
Outstanding shares, exercisable (in shares)		0
Outstanding shares, vested and expected to vest (in shares)		12,165
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning balance (in dollars per share) | $ / shares		$ 0
Weighted average exercise price, exercised (in dollars per share) | $ / shares		0
Weighted average exercise price, forfeited or expired (in dollars per share) | $ / shares		10.93
Weighted average exercise price, ending balance (in dollars per share) | $ / shares		10.93	$ 0
Weighted average exercise price, exercisable (in dollars per share) | $ / shares		0
Weighted average exercise price, vested and expected to vest (in dollars per share) | $ / shares		$ 10.93
Weighted Average Remaining Contractual Term [Abstract]
Weighted average remaining contractual term		4 years 29 days	0 years
Weighted average remaining contractual term, exercised		0 years
Weighted average remaining contractual term, forfeited or expired		0 years
Weighted average remaining contractual term, exercisable		0 years
Weighted average remaining contractual term, vested and expected to vest		4 years 29 days
Aggregate Intrinsic Value [Abstract]
Aggregate intrinsic value, beginning balance | $		$ 0
Aggregate intrinsic value, exercised | $		0
Aggregate intrinsic value, forfeited or expired | $		0
Aggregate intrinsic value, ending balance | $		0	$ 0
Aggregate intrinsic value, exercisable | $		0
Aggregate intrinsic value, vested and expected to vest | $		$ 0
Options exercised (in shares)		0
Time Based Awards [Member] | Executive Chairman [Member]
Outstanding Shares [Abstract]
Outstanding shares, granted (in shares)		56,700
Weighted Average Exercise Price [Abstract]
Weighted average exercise price, granted (in dollars per share) | $ / shares		$ 11.43
Weighted Average Remaining Contractual Term [Abstract]
Weighted average remaining contractual term, granted		4 years 29 days
Aggregate Intrinsic Value [Abstract]
Aggregate intrinsic value, granted | $		$ 0
Number of shares of Stock Options [Abstract]
Granted (in shares)		56,700
1996 Equity Incentive Plan [Member]
Outstanding Shares [Abstract]
Outstanding shares, exercised (in shares)		0	0
Aggregate Intrinsic Value [Abstract]
Shares reserved and available for grant (in shares)		124,888	139,578
Options exercised (in shares)		0	0